Estradiol 1.8 mg Capsules Recalled for Lack of Processing Control
The Medicine Shoppe Pharmacy is recalling Estradiol 1.8 mg capsules due to a lack of processing control. The recall affects products distributed in Florida.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity recall involving potential but unreported health risks.
Plain-English summary
The Medicine Shoppe Pharmacy in Port Charlotte, Florida, is recalling Estradiol 1.8 mg capsules, 30-count bottles. The recall is being conducted due to a lack of processing control. The affected product is identified by Lot 45073 and has a discard-by date of 8/7/2020.
The recall is limited to products distributed in Florida. The source text does not specify the number of units recalled or report any illnesses or injuries associated with the product.
Consumers who have this product should contact The Medicine Shoppe Pharmacy for further instructions on how to return or dispose of the medication.
The recalled product
- Product
- Estradiol 1.8 mg capsule 30 cap bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL
- Manufacturer
- The Medicine Shoppe Pharmacy
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 45073 Discard by: 8/7/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 54 recalled by The Medicine Shoppe Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 54 products in this recall →Related recalls
Same manufacturer · The Medicine Shoppe Pharmacy
See all →- SevereBi-Est Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateDiethylstilbestrol Capsules Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateHydrocortisone Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateTestosterone Gel Recalled by Florida Pharmacy for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateParegoric Alternate Elixir Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
Same hazard · processing control
See all →- ModerateErgotamine Tartrate and Caffeine Suppositories Recalled for Processing Control Issues
FDA (Drugs) · 2020-04-22
- ModerateEstradiol Vaginal Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
Similar recalls
- ModerateMasterPharm Recalls Estriol 8 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Estriol 6 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- HighEpic Pharma Recalls Estradiol Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2019-10-16
- SevereClinical Specialties Compounding Pharmacy Recalls Estradiol Valerate Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- ModerateMasterPharm Recalls Tadalafil 18 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- SevereEstradiol Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23